panCELLa’s Dr. Nagy recently attended the Alliance for Regenerative Medicine’s inaugural Meeting on the Med (April 23rd to April 25th 2019) where he spoke about how panCELLa addresses the two main concerns of cell therapy – safety and universality – with our exclusive and proprietary FailSafe and Induced Allogeneic Cell Tolerance (iACT Stealth Cells)
The Alliance for Regenerative Medicine (ARM) is a multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, DC to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 110 members and is the leading global advocacy organization in this field. panCELLa is proud to be one of those members
The “live” broadcast is available here.
Alternatively scroll through our gallery
-
- Dr. Nagy presents panCELLa
-
- Our IP: leaders in the area of cell therapy safety
-
- panCELLa’s FailSafe was recently featured in Nature
-
- Providing safe therapeutic cell products with FailSafe
-
- Quantifying Risk: The FailSafe Level
-
- Assessing Risk: Allows for Informed Decision.
-
- Efficient & reliable control
-
- Safety Paramount: FailSafe offers control
-
- induced Allogeneic Cell Tollerance (iACT StealthCells )
-
- iACT Stealth Cells
-
- Longterm Allograft Tolerance without the need for systemic immune suppression
-
- Truly allogeneic & off-the-shelf
Sorry, comments are closed for this post.